Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1983 May;80(10):3059–3063. doi: 10.1073/pnas.80.10.3059

Regulation of rat urinary and renal kallikrein and prekallikrein by corticosteroids.

Y Noda, K Yamada, R Igic, E G Erdös
PMCID: PMC393973  PMID: 6344076

Abstract

Rats were adrenalectomized and injected for 7 days with dexamethasone (DEX) or deoxycorticosterone. Kallikrein and prekallikrein were assayed in urine and in a basolateral membrane-enriched fraction. The activities of renin and phospholipase A2 were also determined in the fraction. Adrenalectomy significantly decreased active kallikrein in urine. Administration of deoxycorticosterone raised the level of active kallikrein in urine without affecting the concentration of prekallikrein. Rats treated with DEX only had high Na+ and low active kallikrein excretion. The total kallikrein level (active kallikrein together with prekallikrein), however, returned to normal because DEX elevated the prekallikrein level. DEX also increased the prekallikrein concentration in the membrane-enriched fraction. Renin activity in the membrane-enriched fraction was enhanced by adrenalectomy but suppressed by either corticosteroid. The changes in the concentration of plasma renin were qualitatively similar but quantitatively different. The activity of phospholipase A2 in the membrane-enriched fraction was enhanced only by deoxycorticosterone. Thus, both gluco- and mineralocorticoids increased kallikrein excretion in the adrenalectomized animals, but DEX was apparently effective at a lower dose than deoxycorticosterone. DEX increases the prekallikrein concentration in urine and on the basal membrane of distal tubular cells and, in addition, may prevent its conversion by releasing an inhibitor of a prekallikrein activator.

Full text

PDF
3059

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barr J. G., Diz D., Kauker M. L., Nasjletti A. Effect of the converting enzyme inhibitor SQ-20881 on urinary excretion of prostaglandin E2 in the rat: influence of pretreatment with deoxycorticosterone. J Pharmacol Exp Ther. 1980 Oct;215(1):172–175. [PubMed] [Google Scholar]
  2. Bönner G., Autenrieth R., Marin-Grez M., Rascher W., Gross F. Effects of sodium loading, desoxycorticosterone acetate, and corticosterone on urinary kallikrein excretion. Horm Res. 1981;14(2):87–94. doi: 10.1159/000179365. [DOI] [PubMed] [Google Scholar]
  3. Erdös E. G. Hypotensive peptides: bradykinin, kallidin, and eledoisin. Adv Pharmacol. 1966;4:1–90. doi: 10.1016/s1054-3589(08)60097-6. [DOI] [PubMed] [Google Scholar]
  4. Geller R. G., Margolius H. S., Pisano J. J., Keiser H. R. Effects of mineralocorticoids, altered sodium intake, and adrenalectomy on urinary kallikrein in rats. Circ Res. 1972 Dec;31(6):857–861. doi: 10.1161/01.res.31.6.857. [DOI] [PubMed] [Google Scholar]
  5. Haack D., Möhring J., Möhring B., Petri M., Hackenthal E. Comparative study on development of corticosterone and DOCA hypertension in rats. Am J Physiol. 1977 Nov;233(5):F403–F411. doi: 10.1152/ajprenal.1977.233.5.F403. [DOI] [PubMed] [Google Scholar]
  6. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  7. Margolius H. S., Chao J., Kaizu T. The effects of aldosterone and spironolactone on renal kallikrein in the rat. Clin Sci Mol Med Suppl. 1976 Dec;3:279s–282s. doi: 10.1042/cs051279s. [DOI] [PubMed] [Google Scholar]
  8. Margolius H. S. The kallikrein-kinin system, renal function and hypertensive diseases. Prog Biochem Pharmacol. 1980;17:116–122. [PubMed] [Google Scholar]
  9. Marver D., Schwartz M. J., Kokko J. P. Multiple effects of corticoid hormones on the mammalian nephron. Ann N Y Acad Sci. 1981;372:39–55. doi: 10.1111/j.1749-6632.1981.tb15456.x. [DOI] [PubMed] [Google Scholar]
  10. Nasjletti A., Malik K. U. The renal kallikrein-kinin and prostaglandin systems interaction. Annu Rev Physiol. 1981;43:597–609. doi: 10.1146/annurev.ph.43.030181.003121. [DOI] [PubMed] [Google Scholar]
  11. Nasjletti A., McGiff J. C., Colina-Chourio J. Interrelations of the renal kallikrein-kinin system and renal prostaglandins in the conscious rat. Influence of mineralocorticoids. Circ Res. 1978 Nov;43(5):799–807. doi: 10.1161/01.res.43.5.799. [DOI] [PubMed] [Google Scholar]
  12. Nishimura K., Alhenc-Gelas F., White A., Erdös E. G. Activation of membrane-bound kallikrein and renin in the kidney. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4975–4978. doi: 10.1073/pnas.77.8.4975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nishimura K., Ward P., Erdös E. G. Kallikrein and renin in the membrane fractions of the rat kidney. Hypertension. 1980 Jul-Aug;2(4):538–545. doi: 10.1161/01.hyp.2.4.538. [DOI] [PubMed] [Google Scholar]
  14. Okazaki T., Okita J. R., MacDonald P. C., Johnston J. M. Initiation of human parturition. X. Substrate specificity of phospholipase A2 in human fetal membranes. Am J Obstet Gynecol. 1978 Feb 15;130(4):432–438. [PubMed] [Google Scholar]
  15. Oza N. B., Lieberthal W., Bernard D. B., Levinsky N. G. Antibody that recognizes total human urinary kallikrein: radioimmunological determination of inactive kallikrein. J Immunol. 1981 Jun;126(6):2361–2364. [PubMed] [Google Scholar]
  16. Petty K. J., Kokko J. P., Marver D. Secondary effect of aldosterone on Na-KATPase activity in the rabbit cortical collecting tubule. J Clin Invest. 1981 Dec;68(6):1514–1521. doi: 10.1172/JCI110405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rapp J. P., McPartland R. P., Sustarsic D. L. Anomalous response of urinary kallikrein to deoxycorticosterone in Dahl salt-sensitive rats. Hypertension. 1982 Jan-Feb;4(1):20–26. doi: 10.1161/01.hyp.4.1.20. [DOI] [PubMed] [Google Scholar]
  18. Scicli A. G., Carretero O. A., Hampton A., Cortes P., Oza N. B. Site of kininogenase secretion in the dog nephron. Am J Physiol. 1976 Feb;230(2):533–536. doi: 10.1152/ajplegacy.1976.230.2.533. [DOI] [PubMed] [Google Scholar]
  19. Seifert S. C., Gelehrter T. D. Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6130–6133. doi: 10.1073/pnas.75.12.6130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Vio C. P., Roblero J. S., Croxatto H. R. Dexamethasone, aldosterone and kallikrein release by isolated rat kidney. Clin Sci (Lond) 1981 Aug;61(2):241–243. doi: 10.1042/cs0610241. [DOI] [PubMed] [Google Scholar]
  21. Wade J. B., O'Neil R. G., Pryor J. L., Boulpaep E. L. Modulation of cell membrane area in renal collecting tubules by corticosteroid hormones. J Cell Biol. 1979 May;81(2):439–445. doi: 10.1083/jcb.81.2.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ward P. E., Gedney C. D., Dowben R. M., Erdös E. G. Isolation of membrane-bound renal kallikrein and kininase. Biochem J. 1975 Dec;151(3):755–758. doi: 10.1042/bj1510755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Yamada K., Erdös E. G. Kallikrein and prekallikrein of the isolated basolateral membrane of rat kidney. Kidney Int. 1982 Oct;22(4):331–337. doi: 10.1038/ki.1982.177. [DOI] [PubMed] [Google Scholar]
  24. Yamada K., Schulz W. W., Page D. S., Erdös E. G. Kallikrein and prekallikrein on the basolateral membrane of rat kidney tubules. Hypertension. 1981 Nov-Dec;3(6 Pt 2):II–59-64. doi: 10.1161/01.hyp.3.6_pt_2.ii-59. [DOI] [PubMed] [Google Scholar]
  25. Yatzidis H. New method for direct determination of "true" creatinine. Clin Chem. 1974 Sep;20(9):1131–1134. [PubMed] [Google Scholar]
  26. Yorio T., Bentley P. J. Phospholipase A and the mechanism of action of aldosterone. Nature. 1978 Jan 5;271(5640):79–81. doi: 10.1038/271079a0. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES